EIR Epic Pharma Jan 2003

James Liubicich FDA, Joy Matthias FDA, Robert Steyert FDA$595.00 - Available Now

FDA investigators audited the Epic Pharma - Laurelton, NY, United States facility and issued inspectional observation (via FDA 483) on 16 Jan 2003.

Product details

  • Category:
  • Inspection end: 16 Jan 2003
  • Location: Laurelton, United States
  • FEI: 2431929
Add To Cart